Discussing RA: Long-term effectiveness and sex differences of JAK inhibitors in rheumatoid arthritis
The IMID Forum
- Published
- January 29, 2026
- Duration
- 9:20
- Summary source
- description
- Last updated
- Jun 21, 2026
Discusses Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammat…
Summary
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper by Strand et al. that evaluated TOF efficacy, safety, and persistence by sex, and explored whether age-related factors contribute to differences in treatment response between males and females, and …
Intelligent report
Sign in to read teasers, or upgrade to Research Pro to commission a new dossier for this episode. Learn more →
Show notes
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper by Strand et al. that evaluated TOF efficacy, safety, and persistence by sex, and explored whether age-related factors contribute to differences in treatment response between males and females, and by Alten et al. that explored the long‑term effectiveness of baricitinib and other b/tsDMARDs in patients with RA with early low disease activi